About Cellarity
Cellarity is a company based in Cambridge (United States) founded in 2015 by Avak Kahvejian. Cellarity has raised $294 million across 3 funding rounds from investors including BlackRock, Flagship Pioneering and Kyowa Kirin. The company has 117 employees as of December 31, 2022. Cellarity offers products and services including Cellarity Platform and Pipeline. Cellarity operates in a competitive market with competitors including Asimov, Metaphore, Panakeia, Evolved By Nature and Algorithmic Biologics, among others.
- Headquarter Cambridge, United States
- Employees 117 as on 31 Dec, 2022
- Founders Avak Kahvejian
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$294 M (USD)
in 3 rounds
-
Latest Funding Round
$121 M (USD), Series C
Oct 04, 2022
-
Investors
BlackRock
& 6 more
-
Employee Count
117
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cellarity
Cellarity offers a comprehensive portfolio of products and services, including Cellarity Platform and Pipeline.
Platform for analyzing omics data to design medicines.
System for developing medicines against cellular dysfunction.
People of Cellarity
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Cellarity
Cellarity has successfully raised a total of $294M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $121 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cellarity
Cellarity has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include BlackRock, Flagship Pioneering and Kyowa Kirin.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life sciences-focused venture capital firm
|
Locked | Locked | Locked | |
|
Infrastructure and venture capital firm focused on renewable energy, technology, and life science sectors
|
Locked | Locked | Locked | |
|
Developer of biologics for multiple diseases and disorders
|
Locked | Locked | Locked |
Investor details for Cellarity
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cellarity
Investment portfolio details for Cellarity
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cellarity
Detailed financials for Cellarity
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cellarity Comparisons
Peer comparison for Cellarity
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cellarity
Cellarity operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Asimov, Metaphore, Panakeia, Evolved By Nature and Algorithmic Biologics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of integrated suite for advanced genetic design and manufacturing
|
|
| Locked | Locked | Locked |
Provider of machine language and computational platform for drug discovery
|
|
| Locked | Locked | Locked |
AI-based software is provided for cancer diagnosis and precision treatment.
|
|
| Locked | Locked | Locked |
Digital technology for biomedicinal molecule development in research is utilized.
|
|
| Locked | Locked | Locked |
Provider of software solutions for molecular diagnostics and discovery
|
Detailed competitors of Cellarity
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cellarity
Complete news archive for Cellarity
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellarity
Cellarity was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Cellarity is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Avak Kahvejian is the current CEO of Cellarity. They have also founded this company.
Cellarity is a funded company, having raised a total of $294M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Cellarity is 117.
Cellarity was founded in 2015 in Cambridge, United States, within the biotechnology sector. Single-cell technologies and machine learning are integrated into a platform to digitize and quantify cellular behaviors. Medicines are designed through this approach for applications in hematology, immuno-oncology, metabolism, and respiratory diseases. Operations focus on drug development to address these therapeutic areas.
Cellarity offers Cellarity Platform and Pipeline.
Cellarity has 7 investors. Key investors include BlackRock, Flagship Pioneering, Kyowa Kirin, Hanwha Impact, and The Baupost Group.